0001385508-23-000011.txt : 20230105 0001385508-23-000011.hdr.sgml : 20230105 20230105170345 ACCESSION NUMBER: 0001385508-23-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230105 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Toole David D CENTRAL INDEX KEY: 0001491140 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38193 FILM NUMBER: 23512331 MAIL ADDRESS: STREET 1: 1640 MARENGO STREET CITY: LOS ANGELES STATE: CA ZIP: 90033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OPIANT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001385508 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464744124 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 233 WILSHIRE BLVD STREET 2: SUITE 400 CITY: SANTA MONICA STATE: CA ZIP: 90401 BUSINESS PHONE: (310) 598-5410 MAIL ADDRESS: STREET 1: 233 WILSHIRE BLVD STREET 2: SUITE 400 CITY: SANTA MONICA STATE: CA ZIP: 90401 FORMER COMPANY: FORMER CONFORMED NAME: Lightlake Therapeutics Inc. DATE OF NAME CHANGE: 20091009 FORMER COMPANY: FORMER CONFORMED NAME: Madrona Ventures, Inc. DATE OF NAME CHANGE: 20070108 4 1 wf-form4_167295619781599.xml FORM 4 X0306 4 2023-01-05 0 0001385508 OPIANT PHARMACEUTICALS, INC. OPNT 0001491140 O'Toole David D C/O OPIANT PHARMACEUTICALS, INC. 233 WILSHIRE BOULEVARD, SUITE 400 SANTA MONICA CA 90401 0 1 0 0 Chief Financial Officer Common Stock 2023-01-05 4 S 0 1600 20.20 D 35204 D These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. /s/ David D. O'Toole 2023-01-05